CRI Report: neoantigen cancer vaccine market is expected to grow at a CAGR of 77.73%
The global neoantigen cancer vaccine market is expected to grow at a CAGR of 77.73% during the forecast period 2024-2031, aided primarily by the expected launch of the first neovaccine in the market.
Read More